Vitamin E treatment of tardive dyskinesia
- PMID: 8102511
- DOI: 10.1176/ajp.150.9.1405
Vitamin E treatment of tardive dyskinesia
Abstract
Objective: The authors studied the effects of vitamin E treatment of tardive dyskinesia; earlier studies have produced contradictory results.
Method: Twenty-eight patients with tardive dyskinesia were treated in a double-blind, parallel-group comparison study of 8-12 weeks of treatment with vitamin E (1600 IU/day) or matching placebo capsules.
Results: The Abnormal Involuntary Movement Scale scores of the patients treated with vitamin E improved significantly compared to the scores of the patients given placebo.
Conclusions: These results support earlier findings of the efficacy of vitamin E in treating tardive dyskinesia.
Similar articles
-
Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.Am J Psychiatry. 1992 Mar;149(3):391-3. doi: 10.1176/ajp.149.3.391. Am J Psychiatry. 1992. PMID: 1346951 Clinical Trial.
-
Treatment of tardive dyskinesia with vitamin E.Am J Psychiatry. 1992 Jun;149(6):773-7. doi: 10.1176/ajp.149.6.773. Am J Psychiatry. 1992. PMID: 1350428 Clinical Trial.
-
Vitamin E in the treatment of tardive dyskinesia.Am J Psychiatry. 1990 Apr;147(4):505-6. doi: 10.1176/ajp.147.4.505. Am J Psychiatry. 1990. PMID: 1969247 Clinical Trial.
-
Oxidative mechanisms and tardive dyskinesia.CNS Drugs. 2003;17(1):47-62. doi: 10.2165/00023210-200317010-00004. CNS Drugs. 2003. PMID: 12467492 Review.
-
Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.Ann N Y Acad Sci. 1989;570:176-85. doi: 10.1111/j.1749-6632.1989.tb14918.x. Ann N Y Acad Sci. 1989. PMID: 2576510 Review. No abstract available.
Cited by
-
Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.Drug Saf. 2005;28(3):191-208. doi: 10.2165/00002018-200528030-00002. Drug Saf. 2005. PMID: 15733025 Review.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. Psychopharmacol Bull. 2018. PMID: 29382960 Free PMC article. Review. No abstract available.
-
Natural Medicines for Psychotic Disorders: A Systematic Review.J Nerv Ment Dis. 2018 Feb;206(2):81-101. doi: 10.1097/NMD.0000000000000782. J Nerv Ment Dis. 2018. PMID: 29373456 Free PMC article.
-
Behavioral and antioxidant activity of a tosylbenz[g]indolamine derivative. A proposed better profile for a potential antipsychotic agent.Ann Gen Hosp Psychiatry. 2004 Jan 7;3(1):1. doi: 10.1186/1475-2832-3-1. Ann Gen Hosp Psychiatry. 2004. PMID: 14711381 Free PMC article.
-
Treatment of neurolept-induced tardive dyskinesia.Neuropsychiatr Dis Treat. 2013;9:1371-80. doi: 10.2147/NDT.S30767. Epub 2013 Sep 16. Neuropsychiatr Dis Treat. 2013. PMID: 24072972 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical